Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
11.23
+0.48 (4.47%)
Nov 22, 2024, 4:00 PM EST - Market closed
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 30 employees as of December 31, 2023. The number of employees increased by 2 or 7.14% compared to the previous year.
Employees
30
Change (1Y)
2
Growth (1Y)
7.14%
Revenue / Employee
$1,155,900
Profits / Employee
-$182,700
Market Cap
290.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AngioDynamics | 748 |
Lifecore Biomedical | 524 |
uniQure | 480 |
Poseida Therapeutics | 330 |
NeuroPace | 171 |
Mersana Therapeutics | 123 |
Atai Life Sciences | 83 |
Atea Pharmaceuticals | 75 |
ETON News
- 10 days ago - Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 16 days ago - Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - GlobeNewsWire
- 7 weeks ago - Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewsWire